NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
TORONTO, June 01, 2018 — The Board of Directors of Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or
the “Company”) announced today that Mr. Chris Churchill-Smith will replace Larry Bortles as the Chief Executive Officer of the
Company, effective immediately.
When Mr. Bortles joined the Company’s Board in January 2017 and later accepted the Board’s appointment as Chief
Executive Officer, he expressed his intention to lead the Company through to the pre-sale inspection stage of the application
process under the Access to Cannabis for Medical Purposes Regulations (ACMPR). Mr. Bortles did not deviate from this
course of action. The Board would like to thank Mr. Bortles for his contribution to Canada House during his tenure.
The board requested that Scott Purdy become the Company’s Chairman, which he accepted. Mr. Purdy has been a member
of the Company’s Board and its Audit Committee since April, 2017. Prior to joining Canada House, Mr. Purdy built a number
of disruptive businesses, challenging current thinking and producing a completely new form of business in the healthcare
industry. He is a cannabis professional, holding a MMAR Production License who has legally grown Cannabis since 2013. He
was a CEO for 19 years in the Health Care Industry. He served on the board of directors of Nimble LTD., a product
commercialization company, Sunnybrook Center for Studies in Aging, Sunnybrook Hospital, Toronto ON.
On behalf of the Board, Mr. Purdy is pleased to announce the appointment of Christopher Churchill-Smith as the Company’s
new Chief Executive Officer.
Mr. Churchill-Smith founded Axes Capital in 2012 and has developed extensive transaction experience in the Health Care and
Energy & Infrastructure sectors and has significant experience navigating complex regulatory environments in many
jurisdictions, having executed and led transactions in 3 continents. In the past 5 years, Mr. Churchill-Smith has participated in
investments, as an advisor or investor, totaling in excess of $2.20 Billion in enterprise value. Mr. Churchill-Smith was awarded
the 40 Under 40 Award – Dealmaker Category by The M&A Advisor in June 2014 in New York City, for his participation on the
landmark acquisition of the largest renewable energy platform in Turkey.
Since 2015, Mr. Churchill-Smith has led the acquisitions, as principal, of a leading provider of air ambulance repatriation
services and a significant portfolio of rooftop solar generation facilities in Ontario. In addition, Mr. Churchill-Smith has led the
acquisition and subsequent growth of a leading platform of fertility centers in central Europe.
Mr. Churchill-Smith holds a Bachelor of Arts (Economics and Finance) from McGill University where he was a member of the
McGill Redmen hockey team. Mr. Churchill-Smith played professional hockey from 2008-2010 in the Czech Republic, is fluent
in written and spoken English, French and Italian, and has a basic knowledge of Czech and Slovak.
“The Board is very pleased to welcome Chris to Canada House. His proven track record in deal execution in highly regulated
and health care sectors will without doubt drive Canada House on the execution of its business plan and growth trajectory as a
fully integrated cannabis therapy company,” commented Chairman Scott Purdy. “The addition of Chris, his insight and
perspective will play a major role in Canada House’s future growth.”
Canada House Wellness Group Inc.
Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. The
Company’s goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully
integrated cannabis therapy company. For more information please visit https://www.canadahouse.ca or www.sedar.com.
For further information, please contact:
Canada House Wellness Group Inc.
Cautionary Statement Regarding Forward Looking Information. Certain statements within this news release pertaining to
the Company may constitute “forward looking statements”, within the meaning of applicable securities laws. Forward-looking
statements may be identified by the use of terminology such as “believes,” “expects,” “anticipates,” “assumes,” “plans,” or
other similar words. Such forward-looking statements involve known and unknown risks and uncertainties that could cause
actual and future events to differ materially from those anticipated in such statements. The Company assumes no
responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility
for the adequacy or accuracy of this release.